Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Theophylline on cAMP Signaling in Children With Pseudohypoparathyroidism Type 1a
NCT02463409Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jun 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of theophylline in Pseudohypoparathyroidism Type 1A (PHP1a), sponsored by Vanderbilt University Medical Center. Started Jun 2015; status: completed.
02
Drugs
theophylline
03
Conditions
Pseudohypoparathyroidism Type 1A (PHP1a)
Beyond the preview
Go deeper on NCT02463409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02463409.